medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2016, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2016; 15 (1)


Intrapulmonary vascular dilation in children with chronic liver diseases: pre- and post-liver transplantation

Khositseth A, Treepongkaruna S, Khemakanok K, Teeraratkul S, Pansrimangkorn V, Thirapattaraphan C, Leelaudomlipi S
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 27
Paginas: 47-52
Archivo PDF: 196.32 Kb.


PALABRAS CLAVE

Sin palabras Clave

RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol 2014; 20: 5442-60.

  2. Sussman NL, Kochar R, Fallon MB. Pulmonary complications in cirrhosis. Curr Opin Organ Transplant 2011; 16: 281-8.

  3. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Chest 1990; 98: 1053-4.

  4. Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, Navasa M, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatology 2001; 34: 651-7.

  5. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, Muller C. Hepatopulmonary syndrome: Prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002; 51: 853-9.

  6. Noli K, Solomon M, Golding F, Charron M, Ling SC. Prevalence of hepatopulmonary syndrome in children. Pediatrics 2008; 121: e522-e527.

  7. Lange PA, Stoller JK. The hepatopulmonary syndrome. Effect of liver transplantation. Clin Chest Med 1996; 17: 115-23.

  8. Schneider BL, Suchy FJ, Emre S. National and regional analysis of exceptions to the pediatric end-stage liver disease scoring system (2003-2004). Liver Transpl 2006; 12: 40-5.

  9. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109: 1283-8.

  10. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (ipvd) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97: 1165-70.

  11. Gudavalli A, Kalaria VG, Chen X, Schwarz KQ. Intrapulmonary arteriovenous shunt: Diagnosis by saline contrast bubbles in the pulmonary veins. J Am Soc Echocardiogr 2002; 15: 1012-14.

  12. Lao AY, Sharma VK, Tsivgoulis G, Frey JL, Malkoff MD, Navrro JC, Alexandrov AV. Detection of right-to-left shunts: Comparison between the international consensus and spencer logarithmic scale criteria. J Neruroimaging 2008; 18: 402-6.

  13. Wade OL, Bishop JM. Cardiac output and regional blood flow. Oxford, England: Blackwell Scientific; 1962.

  14. Varghese J, Ilias-basha H, Dhanasekaran R, Singh S, Venkataraman J. Hepatopulmonary syndrome - past to present. Ann Hepatology 2007; 6: 135-42.

  15. de Macedo LG, Lopes EP. Hepatopulmonary syndrome: An update. Sao Paulo Med J 2009; 127: 223-30.

  16. Cremon G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, Roe P, et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Resp J 1995; 8: 1883-5.

  17. Porres-Aguilar M, Altamirano JT, Torre-Delgadillo A, Charlton MR, Duarte-Rojo A. Portopulmonary hypertension and hepatopulmonary syndrome: A clinician-oriented overview. Eur Resp Review 2012; 21: 223-33.

  18. Castro M, Krowka MJ. Hepatopulmonary syndrome: A pulmonary vascular complication of liver disease. Clin Chest Med 1996; 17: 35-48.

  19. Shub C, Tajik AJ, Seward JB, Dines DE. Detecting intrapulmonary right-to-left shunt with contrast echocardiography. Observations in a patient with diffuse pulmonary arteriovenous fistulas. Mayo Clin Proc 1976; 51: 81-4.

  20. Khan AN, Al-Jahdali H, Abdullah K, Irion KL, Sabih Q, Gouda A. Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment. Ann Thorac Med 2011; 6: 57-65.

  21. El-Shabrawi MH, Omran S, Wageeh S, Isa M, Okasha S, Mohsen NA, Zekry O, et al. (99m)technetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease. Eur J Gastroenterol Hepatol 2010; 22: 1006-12.

  22. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: A new approach. Gastroenterology 1998; 114: 305-10.

  23. Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: Distinctions and dilemmas. Hepatology 1997; 25: 1282-4.

  24. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, Committee ERSTFP-HVDS. Pulmonary-hepatic vascular disorders (phd). Eur Resp J 2004; 24: 861-80.

  25. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology 2000; 32: 859-65.

  26. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003; 37: 192-7.

  27. Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998; 11: 1153-66.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2016;15

ARTíCULOS SIMILARES

CARGANDO ...